Piebaldism is an autosomal dominant genetic disorder characterized by congenital patches of skin and har from which melanocytes are completely absent. A similar disorder of mouse, dominant white spotting (W), results from mutations of the c-Kit protooncogene, which encodes the receptor for mast/stem cell growth factor. We identified a KIT gene mutation in a proband with classic autosomal dint piebaldism. This mutation results in a Gly --Arg substitution at codon 664, within the tyrosine kinase domain. This substitution was not seen in any normal individuals and was completely linked to the piebald phenotype in the proband's family. Piebaldism in this family thus appears to be the human homologue to dominant white spotting (W) of the mouse.
albinism, was one of the first autosomal dominant disorders recognized (5) . Piebaldism was also one of the first genetic disorders for which a pedigree was presented (6, 7) , and several pedigrees have been reported in which the disorder has been traced over hundreds of years (for review, see ref. 3) . A similar phenotype in the mouse, dominant white spotting (W), has recently been shown to result from deletions or point mutations within the Kit protooncogene (8) (9) (10) (11) , which encodes the tyrosine kinase transmembrane cellular receptor for mast/stem cell growth factor (12) (13) (14) (15) . The human piebaldism locus was provisionally mapped to chromosome segment 4q12 on the basis of interstitial chromosomal deletions (16) (17) (18) (19) , coincident with the location of the human KIT protooncogene in chromosome segment 4q11-q12 (20, 21) . This result suggested that human piebaldism might, like mouse dominant white spotting, also result from mutations of the c-kit gene.
We have determined the DNA sequence of the normal human KITgene to facilitate analyses of human KITgenomic DNA segments from probands with piebaldism using the PCR. Here, we report a missense mutation, resulting in a Gly -* Arg substitution at codon 664, within white forelocks in addition to nonpigmented skin patches. His irides and retinae were normally pigmented, and hearing and visual acuity were normal. There was no family history of dysmorphic facial features, deafness, or anemia, and complete blood count and red cell morphology, both of the proband and two other affected family members, were normal. The proband was a member of a very extensive Ashkenazi Jewish kindred that can trace the inheritance of piebaldism through at least 15 generations (Fig. 1) .
PCR Ampliation and Sequencing of Genomic DNA. Human KIT cDNA phckit-171 (20) Fig. 1 . A 250-bp fragment of the KIT gene consisting of coding exon 13 (codons 627-664; unpublished data) plus portions of the adjacent intervening sequences was PCR-amplified from each as described above, by using a pair of 19-mer oligonucleotide primers, 5-CATCAGTTTGCCAGTTGTG-3'/5'-TT-TATAATCTAGCATTGCC-3', derived from the KIT genomic nucleotide sequence (unpublished data). The products of the amplification reactions were cleaved with Mnl I, electrophoresed through 6% polyacrylamide gels, and scored for the presence of the codon-664 mutation. Linkage was assessed by determination of logarithm of odds (lod) scores using version 3 (1987) of the LIPED-program (26), assuming complete penetrance and an estimated frequency of lo-' for piebaldism.
RESULTS
Nucleotide Sequence Analysis of the KIT Gene of the Proband. Southern blot analysis ofthe proband's DNA, using KIT cDNA and genomic fragments as probes, identified no KIT gene deletion or other rearrangement (data not shown). Therefore, all 21 KIT-coding exons, plus adjacent portions of the intervening and 5' and 3'-untranslated and -flanking sequences, were amplified by PCR and sequenced from DNA of the proband. This analysis demonstrated only a single difference from the normal gene, a GGG --AGG substitution within codon 664, the last base ofcoding exon 13 (Fig. 2) . This results in a Gly Arg substitution in the tyrosine kinase domain of KIT. As expected for an autosomal dominant disorder, the proband was heterozygous for this change.
To determine whether the codon-664 substitution is a common nonpathologic polymorphism, we took advantage of the fact that this substitution eliminates a Mnl I restriction enzyme cleavage site (5'-GAGG-3'/5'-CCTC-3'). PCR fragments (250 bp) of KIT-coding exon 13 were amplified from DNA of 22 unrelated normal individuals of northern European Caucasian ethnic origin, cleaved with Mnl I, and analyzed by gel electrophoresis. All exhibited only the normal pattern (data not shown). To determine whether the codon-664 substitution is a nonpathologic polymorphism restricted to the Ashkenazi Jewish population, we also analyzed KIT exon 13 PCR fragments amplified from DNA of 17 unrelated normal individuals of Ashkenazi Jewish ethnic origin. As shown in Fig. 3 , the proband exhibited an equal mixture of the normal pattern (99-bp, 89-bp, and 62-bp fragments) plus the abnormal pattern (161-bp and 89-bp fragments), consistent with his being heterozygous for the codon-664 substitution. In contrast, all of the normal individuals exhibit only the normal pattern. Together, these data indicate that the codon-664 substitution is not a common polymorphism, in either the general northern European Caucasian or Ashkenazi Jewish populations.
Genetic Linkage Analysis. To determine whether the codon-664 mutation is genetically linked to piebaldism in the proband's family, we amplified coding exon-13 fragments by PCR of DNA from both normal family members and those affected with piebaldism. The amplified exon-13 fragments were then analyzed by Mnl I cleavage, as described above (data not shown). As illustrated in Fig. 1 , there was perfect concordance between heterozygosity for the codon-664 mutant allele and the piebald phenotype in this family; all affected family members exhibited an equal mixture of both the normal and abnormal fragments, and all normal individuals exhibited only the normal fragments. Two-point linkage analysis, performed with the LIPED program (27) , yielded a maximal logarithm of odds (lod) score of 6.02 at 0 = 0. These data thus strongly support the hypothesis that piebaldism in this family is tightly linked to the KIT protooncogene.
DISCUSSION
Piebaldism is a rare autosomal dominant disorder characterized by congenital patches of skin and hair in which pigment is entirely lacking. The characteristic nonpigmented patches, most prominent over ventral surfaces of the face, chest, trunk, and extremities, and the white forelock are present at birth and do not change over time. We have shown that in the study family, piebaldism is linked to a missense substitution at codon 664 of the KIT protooncogene, which encodes the cell-surface receptor for mast/stem cell growth factor (12) (13) (14) (15) . This mutation, within the tyrosine kinase domain of KIT, is similar to those observed in W mutant mice (9-11) and exhibited complete genetic linkage to the piebald phenotype in this family. Furthermore, we did not observe this mutation among normal individuals, indicating that it is not a common polymorphism. Recently, we studied three additional families with piebaldism and identified three different KIT gene mutations, a missense substitution and two frameshifts that are completely linked to piebaldism (unpublished data). It is thus apparent that in these families mutations of the KIT protooncogene constitute the molecular basis of piebaldism, which thus represents the human homologue of dominant white spotting (W) of mice.
The c-kit gene, originally identified in the genome of the HZ4-feline sarcoma virus isolated from a feline leukemia virus-associated feline fibrosarcoma (28) White spotting in human piebaldism results from the absence of melanocytes from the nonpigmented patches of skin (31) and from hairbulbs in the white patches of hair (32) , apparently because of defective migration of melanoblasts from the neural crest to the epidermis during development. Humans (33, 34) and mice (35) with piebaldism and other white spotting disorders, such as Waardenburg syndrome, occasionally also lack ganglion cells of the intestinal enteric neural plexus, which, like melanoblasts, are derived embryologically from the neural crest. In this regard, it is perhaps noteworthy that several affected members of this study family reported lifelong severe constipation, possibly the result of defective migration of enteric-plexus ganglion cells from the neural crest to the gut.
The KIT gene product is one of a family of transmembrane tyrosine kinase receptors that also include the plateletderived growth factor receptor a and 18 chains and the colony-stimulating factor 1 receptor (20) . The genes encoding platelet-derived growth factor receptor 1 chain and colonystimulating factor 1 receptor (c-fms) are closely linked in chromosome segment 5q31-q33 (36, 37) . Similarly, the platelet-derived growth factor receptor a chain and KIT genes both map near each other in chromosome segment 4q11-q12 (20, 21, 38, 39) . Deletion of the platelet-derived growth factor receptor a locus has recently been associated with another dominant white spotting disorder in mouse, called patch (Ph) (40) , and a third dominant white spotting disorder of mouse, rump-white (Rw), is very closely linked genetically to both W and Ph. Accordingly, it is not unlikely that other human genetic disorders with phenotypes of piebaldism-like white spotting may also be associated with defects of these loci in humans.
